Viewing Study NCT04850157


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-01-01 @ 9:17 PM
Study NCT ID: NCT04850157
Status: UNKNOWN
Last Update Posted: 2021-04-20
First Post: 2021-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module